543 Efficacy and safety of desmopressin “add-on” therapy in men with persistent nocturia under alpha blocker monotherapy for lower urinary tract symptoms: A randomized, double-blind, placebo-controlled study

Lower Urinary Tract ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Alpha Blocker ◽

Urinary Tract Symptoms ◽

Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Study

The Journal of Urology ◽

10.1016/j.juro.2016.08.116 ◽

2017 ◽

Vol 197 (2) ◽

pp. 459-464 ◽

Cited By ~ 9

Author(s):

Joon Chul Kim ◽

Kang Jun Cho ◽

Jeong Gu Lee ◽

Ju Tae Seo ◽

Duk Yoon Kim ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Efficacy and Safety of Extended-Release Oxybutynin in Combination With Tamsulosin for Treatment of Lower Urinary Tract Symptoms in Men: Randomized, Double-Blind, Placebo-Controlled Study

Mayo Clinic Proceedings ◽

10.4065/83.9.1002 ◽

2008 ◽

Vol 83 (9) ◽

pp. 1002-1010 ◽

Cited By ~ 80

Author(s):

Scott A. MacDiarmid ◽

Kenneth M. Peters ◽

Andrew Chen ◽

Robert B. Armstrong ◽

Camille Orman ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Extended Release ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Vaginal oestradiol for the treatment of lower urinary tract symptoms in postmenopausal womena double-blind placebo-controlled study

Journal of Obstetrics and Gynaecology ◽

10.1080/01443610120059941 ◽

2001 ◽

Vol 21 (4) ◽

pp. 383-385 ◽

Cited By ~ 34

Author(s):

Linda D. Cardozo, B. G. Wise, C. J. Benne

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Faculty Opinions recommendation of A multicenter, randomized, double-blind, placebo controlled study of onabotulinumtoxinA 200 U to treat lower urinary tract symptoms in men with benign prostatic hyperplasia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718270633.793512123 ◽

2015 ◽

Author(s):

Peter Gilling

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of OnabotulinumtoxinA 200 U to Treat Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia

The Journal of Urology ◽

10.1016/j.juro.2014.02.004 ◽

2014 ◽

Vol 192 (1) ◽

pp. 150-156 ◽

Cited By ~ 27

Author(s):

Kevin T. McVary ◽

Claus G. Roehrborn ◽

Emmanuel Chartier-Kastler ◽

Mitchell Efros ◽

Denise Bugarin ◽

...

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Initial combined treatment with anticholinergics and α-blockers for men with lower urinary tract symptoms related to BPH and overactive bladder: a prospective, randomized, multi-center, double-blind, placebo-controlled study

Prostate Cancer and Prostatic Diseases ◽

10.1038/pcan.2011.22 ◽

2011 ◽

Vol 14 (4) ◽

pp. 320-325 ◽

Cited By ~ 29

Author(s):

S H Lee ◽

B H Chung ◽

S J Kim ◽

J H Kim ◽

J C Kim ◽

...

Keyword(s):

Urinary Tract ◽

Overactive Bladder ◽

Lower Urinary Tract ◽

Combined Treatment ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Efficacy and Safety of an Alpha-Blocker With and Without Anticholinergic Agent in the Management of Lower Urinary Tract Symptoms With Detrusor Overactivity

UroToday International Journal ◽

10.3834/uij.1944-5784.2009.12.02 ◽

2009 ◽

Vol 02 (06) ◽

Cited By ~ 2

Author(s):

Nayayn Kumar Mohanty ◽

Anup Kumar ◽

Manoj Jain ◽

Sanjay Prakash ◽

Rajender Prakash Arora

Keyword(s):

Urinary Tract ◽

Detrusor Overactivity ◽

Lower Urinary Tract ◽

Anticholinergic Agent ◽

Efficacy And Safety ◽

Alpha Blocker ◽

Urinary Tract Symptoms ◽

Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled Trial

European Urology ◽

10.1016/j.eururo.2011.08.005 ◽

2011 ◽

Vol 60 (5) ◽

pp. 1105-1113 ◽

Cited By ~ 119

Author(s):

Hartmut Porst ◽

Edward D. Kim ◽

Adolfo R. Casabé ◽

Vincenzo Mirone ◽

Roberta J. Secrest ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms

Urology ◽

10.1016/s0090-4295(01)01442-x ◽

2001 ◽

Vol 58 (6) ◽

pp. 960-963 ◽

Cited By ~ 61

Author(s):

Glenn S Gerber ◽

Dimitri Kuznetsov ◽

Bernard C Johnson ◽

Jay D Burstein

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Controlled Trial ◽

Double Blind ◽

Saw Palmetto ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial

Arab Journal of Urology ◽

10.1016/j.aju.2016.11.001 ◽

2017 ◽

Vol 15 (1) ◽

pp. 53-59 ◽

Cited By ~ 10

Author(s):

Amr Fawzi ◽

Mostafa Kamel ◽

Emad Salem ◽

Esam Desoky ◽

Mohamed Omran ◽

...

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽